Phase II and Phase III attrition rates 2011–2012. Arrowsmith, J. & Miller, P. Nature Reviews Drug Discovery, 12(8):569–569, August, 2013.
Phase II and Phase III attrition rates 2011–2012 [link]Paper  doi  bibtex   
@article{arrowsmith_phase_2013-1,
	title = {Phase {II} and {Phase} {III} attrition rates 2011–2012},
	volume = {12},
	issn = {1474-1776, 1474-1784},
	url = {http://www.nature.com/articles/nrd4090},
	doi = {10.1038/nrd4090},
	language = {en},
	number = {8},
	urldate = {2019-05-02},
	journal = {Nature Reviews Drug Discovery},
	author = {Arrowsmith, John and Miller, Philip},
	month = aug,
	year = {2013},
	pages = {569--569},
	file = {Arrowsmith and Miller - 2013 - Phase II and Phase III attrition rates 2011–2012.pdf:/Users/neil.hawkins/Zotero/storage/5SVHGHEC/Arrowsmith and Miller - 2013 - Phase II and Phase III attrition rates 2011–2012.pdf:application/pdf},
}

Downloads: 0